Investigation Overview
San Diego, Oct. 19, 2011 (Shareholders Foundation) -- The announcement that Adolor Corp. agreed to be acquired by Cubist Pharmaceuticals, Inc. caused an investigation on behalf of investors of Adolor Corporation (NASDAQ: ADLR) concerning whether the offer to acquire Adolor Corporation and the buyout process are unfair to investors of Adolor Corp. (NASDAQ:ADLR) and whether certain of ...
You must register (for free) or login to view the entire investigation.